Skip to main content
Top
Gepubliceerd in: Quality of Life Research 8/2020

25-03-2020

The impact of metabolic syndrome on mental health-related quality of life and depressive symptoms

Auteurs: Victoria M. Limon, Miryoung Lee, Brandon Gonzalez, Audrey C. Choh, Stefan A. Czerwinski

Gepubliceerd in: Quality of Life Research | Uitgave 8/2020

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

Results examining associations between metabolic syndrome (MetS) and depression, as well as on quality of life (QoL), are inconsistent. We aimed to determine whether individuals with MetS had decreased mental health-related QoL (MH-QoL) and higher frequency of depressive symptoms.

Methods

Data from 1,015 participants from the Fels Longitudinal Study were analyzed (mean age ± SD: 49.6 ± 18.7 years, 29.3% MetS, 51% females). MetS was determined using American Heart Association/National Heart, Lung, and Blood Institute criteria. Depressive symptoms (yes vs. no) were assessed with The Patient Health Questionnaire-9 (PHQ-9). MH-QoL (low (≤ 42) vs. high) was assessed with The Medical Outcomes 36-Item Short Form Survey (SF-36). Sex- and age-stratified mixed effects logistic regressions were used to examine the longitudinal relationship between MetS and MH-QoL while adjusting for covariates such as age, smoking status, and drinking status.

Results

In cross-sectional analysis, MetS was significantly associated with elevated depressive symptoms in women (OR 2.14, 95% CI 1.22–3.78, p < 0.01), but not in men. In the longitudinal analysis, MetS was observed to have a protective effect among men in the older age group as it approached significance (OR 0.34, 95% CI 0.11–1.05, p = 0.06).

Conclusion

MetS was adversely associated with depressive symptoms and poor MH-QoL. Our cross-sectional results suggest that depressive symptoms are higher among women with MetS. Interestingly, our longitudinal results suggest that MH-QoL in men with MetS may improve with age.
Literatuur
6.
go back to reference Services, S. O. T. U. S. D. O. H. A. H. (2018). Health, United States, 2017: With Special Feature on Mortality (Health, United States). Hyattsville, MD: National Center for Health Statistics Services, S. O. T. U. S. D. O. H. A. H. (2018). Health, United States, 2017: With Special Feature on Mortality (Health, United States). Hyattsville, MD: National Center for Health Statistics
11.
12.
go back to reference Simon, G. E. (2001). Treating depression in patients with chronic disease: Recognition and treatment are crucial; Depression worsens the course of a chronic illness. Western Journal of Medicine,175(5), 292–293.CrossRefPubMedPubMedCentral Simon, G. E. (2001). Treating depression in patients with chronic disease: Recognition and treatment are crucial; Depression worsens the course of a chronic illness. Western Journal of Medicine,175(5), 292–293.CrossRefPubMedPubMedCentral
17.
22.
go back to reference Roche, A. F. (1992). Growth, maturation, and body composition: The Fels Longitudinal Study, 1929–1991. New York: Cambridge University Press.CrossRef Roche, A. F. (1992). Growth, maturation, and body composition: The Fels Longitudinal Study, 1929–1991. New York: Cambridge University Press.CrossRef
23.
go back to reference Alberti, K. G., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., et al. (2009). Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation,120(16), 1640–1645. https://doi.org/10.1161/CIRCULATIONAHA.109.192644.CrossRefPubMed Alberti, K. G., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., et al. (2009). Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation,120(16), 1640–1645. https://​doi.​org/​10.​1161/​CIRCULATIONAHA.​109.​192644.CrossRefPubMed
24.
go back to reference The multiple risk factor intervention trial (MRFIT). (1976). A national study of primary prevention of coronary heart disease. JAMA,235(8), 825–827.CrossRef The multiple risk factor intervention trial (MRFIT). (1976). A national study of primary prevention of coronary heart disease. JAMA,235(8), 825–827.CrossRef
26.
go back to reference Kroenke, K., Spitzer, R. L., & Williams, J. B. (2001). The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine,16(9), 606–613.CrossRefPubMedPubMedCentral Kroenke, K., Spitzer, R. L., & Williams, J. B. (2001). The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine,16(9), 606–613.CrossRefPubMedPubMedCentral
28.
go back to reference Ware, J., Snow, K., Kosinski, M., & Gandek, B. (1993). SF-36 health survey: Manual and interpretation guide. Boston, MA: The Health Institute, New England Medical Center Hospitals Inc. Ware, J., Snow, K., Kosinski, M., & Gandek, B. (1993). SF-36 health survey: Manual and interpretation guide. Boston, MA: The Health Institute, New England Medical Center Hospitals Inc.
30.
go back to reference Jenkinson, C. (1999). Comparison of UK and US methods for weighting and scoring the SF-36 summary measures. Journal of Public Health Medicine,21(4), 372–376.CrossRefPubMed Jenkinson, C. (1999). Comparison of UK and US methods for weighting and scoring the SF-36 summary measures. Journal of Public Health Medicine,21(4), 372–376.CrossRefPubMed
36.
go back to reference Vetter, M. L., Wadden, T. A., Lavenberg, J., Moore, R. H., Volger, S., Perez, J. L., et al. (2011). Relation of health-related quality of life to metabolic syndrome, obesity, depression and comorbid illnesses. International Journal of Obesity (Lond),35(8), 1087–1094. https://doi.org/10.1038/ijo.2010.230.CrossRef Vetter, M. L., Wadden, T. A., Lavenberg, J., Moore, R. H., Volger, S., Perez, J. L., et al. (2011). Relation of health-related quality of life to metabolic syndrome, obesity, depression and comorbid illnesses. International Journal of Obesity (Lond),35(8), 1087–1094. https://​doi.​org/​10.​1038/​ijo.​2010.​230.CrossRef
48.
go back to reference Singer, J., & Willett, J. (2003). Applied longitudinal data analysis: Modeling change and event occurrence. New York: Oxford University Press.CrossRef Singer, J., & Willett, J. (2003). Applied longitudinal data analysis: Modeling change and event occurrence. New York: Oxford University Press.CrossRef
Metagegevens
Titel
The impact of metabolic syndrome on mental health-related quality of life and depressive symptoms
Auteurs
Victoria M. Limon
Miryoung Lee
Brandon Gonzalez
Audrey C. Choh
Stefan A. Czerwinski
Publicatiedatum
25-03-2020
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 8/2020
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-020-02479-5

Andere artikelen Uitgave 8/2020

Quality of Life Research 8/2020 Naar de uitgave